{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:11:50Z","timestamp":1787969510224,"version":"build-2784847793"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Febrile neutropenia, neurotoxicity, and cytokine release syndrome are dangerous and damaging side effects seen in more than half of patients with cancer who receive critical chemotherapies or immunotherapies respectively. Early intervention and care can reduce complications, but timely treatment in the outpatient setting is often delayed due to dependency on interval-based, patient-driven self-assessments. Using digital health technologies (DHT) to monitor patients remotely can improve time-to-intervention and health outcomes. Providing follow-up treatment and essential support to patients at home can further reduce patients\u2019 and caregivers\u2019 burden and improve patient satisfaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This pilot feasibility study examined the results of a patient-centered program for technology-assisted remote patient monitoring and symptom reporting for patients undergoing autologous or allogeneic stem cell transplant (SCT) or CAR T-cell therapy. Technical and operational feasibility and user experience were assessed for patients, caregivers, and providers. Ten patients between 30 and 80 years old participated in the study for up to 30 days after CAR T-cell therapy or autologous SCT or up to 90 days after allogeneic SCT. Patients wore biometric sensors around the clock to monitor vital signs and engaged with a chatbot through bidirectional SMS text messages for symptom reporting and regular health check-ins. Virtual care center personnel monitored patient status and followed up with patients or their care providers as needed. Patients, caregivers, and providers completed surveys about their program experience; patients also completed brief interviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine of 10 patients engaged with DHT based monitoring as intended. A total of 219 alerts were generated, 171 from wearables and 48 from the chatbot and check-ins. Fifty-seven alerts required follow-up with patients, 26 required care team follow-up, and 10 required patients to be seen in a clinical setting. Users found the program acceptable overall, with patients and caregivers reporting perceptions of being more cared for and providers feeling that it improved quality of care. Suggestions received included a desire for more information and improved communication and alerting processes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Overall, DHT-based remote patient monitoring was feasible for use with patients receiving SCT and CAR T-cell therapy. Effective practice integration requires adaptation to clinical workflows. Further evaluation of patient acceptance over time and effectiveness at improving health outcomes is recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1403249","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:16:29Z","timestamp":1750205789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Using technology for patient-centered care at home after CAR T-cell therapy or stem cell transplant: a prospective feasibility study"],"prefix":"10.3389","volume":"16","author":[{"given":"Susan L.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen J.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bellinda K.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel K.","family":"Brahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Hoople","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702503","article-title":"Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for Malignancies","volume":"26","author":"Celebi","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00016","article-title":"Outpatient management of fever and neutropenia in adults treated for Malignancy: American society of clinical oncology and infectious diseases society of America clinical practice guideline update summary","volume":"14","author":"Taplitz","year":"2018","journal-title":"J Oncol Pract"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac074","article-title":"Chemotherapy-induced neutropenia and febrile neutropenia in the US: A beast of burden that needs to be tamed","volume":"27","author":"Boccia","year":"2022","journal-title":"Oncologist"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.7528","article-title":"Rates of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) from Center for International Blood and Marrow Transplant Research (CIBMTR) data on US subjects (SUBJ) with lymphoma following chimeric antigen receptor T cell therapy (CAR-T)","volume":"41","author":"Frigault","year":"2023","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-021-01948-2","article-title":"CAR T-cell therapy and critical care: A survival guide for medical emergency teams","volume":"133","author":"Messmer","year":"2021","journal-title":"Wien Klin Wochenschr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"New Engl J Medicine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202200130","article-title":"A computational model of cytokine release syndrome during CAR T-cell therapy","volume":"5","author":"Zhang","year":"2022","journal-title":"Adv Ther (Weinh)"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-94353-0_27","article-title":"Management of immune effector cell-associated neurotoxicity syndrome (ICANS)","volume-title":"The EBMT\/EHA CAR-T Cell Handbook","author":"Rees","year":"2022"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02561-14","article-title":"Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia","volume":"58","author":"Rosa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08693.x","article-title":"Improving the immediate management of neutropenic sepsis in the UK: lessons from a national audit","volume":"153","author":"Clarke","year":"2011","journal-title":"Br J Haematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1086\/588290","article-title":"The influence of mucositis on oral thermometry: when fever may not reflect infection","volume":"46","author":"Ciuraru","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7748\/ns.24.42.42.s49","article-title":"Best practice in the measurement of body temperature","volume":"24","author":"Davie","year":"2010","journal-title":"Nurs Stand"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2009.03.006","article-title":"A comparison between infrared tympanic thermometry, oral and axilla with rectal thermometry in neutropenic adults","volume":"13","author":"Dzarr","year":"2009","journal-title":"Eur J Oncol Nurs"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181cc4824","article-title":"Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department","volume":"38","author":"Gaieski","year":"2010","journal-title":"Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1109\/EMBC44109.2020","article-title":"Cardiac function monitoring for patients undergoing cancer treatments using wearable seismocardiography: A proof-of-concept study","volume":"2020","author":"Hasan Shandhi","year":"2020","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.21.00126","article-title":"Feasibility of wearable-based remote monitoring in patients during intensive treatment for aggressive hematologic Malignancies","volume":"6","author":"Jacobsen","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.28328","article-title":"Effect of remote monitoring on discharge to home, return to activity, and rehospitalization after hip and knee arthroplasty: A randomized clinical trial","volume":"3","author":"Mehta","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2196\/36066","article-title":"Assessing the usability of a novel wearable remote patient monitoring device for the early detection of in-hospital patient deterioration: observational study","volume":"6","author":"Itelman","year":"2022","journal-title":"JMIR Form Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.08.034","article-title":"A wearable patch based remote early warning score (REWS) in major abdominal cancer surgery patients","volume":"49","author":"van der Stam","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1109\/EMBC44109.2020","article-title":"Feasibility of continuous monitoring of core body temperature using chest-worn patch sensor","volume":"2020","author":"Rajbhandary","year":"2020","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2022-002430","article-title":"Remote patient monitoring in the management of chronic obstructive pulmonary disease","volume":"70","author":"Chalupsky","year":"2022","journal-title":"J Invest Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2022.05.005","article-title":"Applications of remote patient monitoring","volume":"49","author":"Kruklitis","year":"2022","journal-title":"Prim Care"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2202046","article-title":"Chronic disease management in heart failure: focus on telemedicine and remote monitoring","volume":"22","author":"Alvarez","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05539-1","article-title":"Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives","volume":"28","author":"Aapro","year":"2020","journal-title":"Support Care Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"n1647","DOI":"10.1136\/bmj.n1647","article-title":"Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)","volume":"374","author":"Maguire","year":"2021","journal-title":"Bmj"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25012","article-title":"Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial","volume":"61","author":"Orme","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B29","unstructured":""},{"key":"B30","unstructured":""},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164747","article-title":"A retrospective observational study of continuous wireless vital sign monitoring via a medical grade wearable device on hospitalized floor patients","volume":"13","author":"Weller","year":"2024","journal-title":"J Clin Med"},{"key":"B32","unstructured":"510(k) clearance letter\n          \n          \n          \n          2022"},{"key":"B33","unstructured":""},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software partners","author":"Harris","year":"2019","journal-title":"J BioMed Inform"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J BioMed Inform"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29734","article-title":"Remote symptom monitoring of patients with cancer undergoing radiation therapy","volume":"14","author":"Wahidi","year":"2022","journal-title":"Cureus"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/CAT.23.0365","article-title":"Remote patient monitoring to transform management of febrile neutropenia in cancer patients","volume":"5","author":"Pritchett","year":"2024","journal-title":"NEJM Catal Innov Care Deliv"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101005","article-title":"Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium","volume":"44","author":"Franzoi","year":"2024","journal-title":"Lancet Regional Health \u2013 Europe"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.e13652","article-title":"A feasibility study of remote patient monitoring among vulnerable patients with cancer","volume":"40","author":"Kessler","year":"2022","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc1134","article-title":"Do stress-related psychosocial factors contribute to cancer incidence and survival","volume":"5","author":"Chida","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.1838","article-title":"Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum","volume":"183","author":"Ayers","year":"2023","journal-title":"JAMA Internal Medicine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1403249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:16:31Z","timestamp":1750205791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1403249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2025.1403249"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1403249","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1403249"}}